Treating coagulopathy in trauma patients

Transfusion Medicine Reviews

Volumn 17, Issue 3, 2003, Pages 223-231

  Armand, Ray ^b   Hess, John R ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACIDOSIS; BLEEDING; BLOOD CLOTTING DISORDER; DILUTION; HUMAN; HYPOTHERMIA; INJURY; REVIEW; THROMBOCYTE; WARMING;

EID: 0042845839     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(03)00022-1     Document Type: Article

References (49)

1. Sauaia A, Moore FA, Moore EE, et al: Epidemiology of trauma teadts: A reassessment. J Trauma 38:185-193, 1995
2. Bellamy RF, Maningas PA, Vayer JS: Epidemiology of trauma: Military experience. Ann Emerg Med 15:1384-1388, 1986
3. Carrico CJ, Holcomb JB, Chaudry IH and PULSE Trauma Work Group: Scientific priorities and strategic planning for resuscitation research and life saving therapy following traumatic injury: Report of the PULSE Trauma Work Group. Acad Emerg Med 9:621-626, 2002
4. Committee on Trauma: Advanced Trauma Life Support for Doctors, Instructional Manual (ed 6). Chicago IL, American College of Surgeons, 1997
5. Cosgriff N, Moore EE, Sauaia A, et al: Predicting life-threatening in the massively transfused trauma patient: Hypothermia and acidosis revisited. J Trauma 42:857-861, 1997
6. Collins JA: The pathophysiology of hemorrhagic shock, in Collins JA, Murawski K, Shafer AW (eds): Massive Transfusion in Surgery and Trauma New York, NY, Liss, 1982, pp 5-29
7. Reiss RF: Hemostatic defects in massive transfusion: Rapid diagnosis and management. Am J Crit Care 9:158-165, 2000
8. Slichter SJ: Identification and management of defects in platelet hemostasis in massively transfused patients, in Collins JA, Murawski K, Shafer AW (eds): Massive Transfusion in Surgery and Trauma New York, NY, Liss, 1982, pp 225-258
9. Burch JM, Denton JR, Noble RD: Physiologic rationale for abbreviated laparotomy, Surg Clin North Am 77:779-782, 1997
10. Watts DD, Trask A, Soeken K, et al: Hypothermic coagulopathy in trauma: Effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 44:846-854, 1998
11. Kermode JC, Zheng Q, Milner EP: Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 94:199-207, 1999
12. Jurkovich GJ, Greiser WB, Luterman A, et al: Hypothermia in trauma victims: An ominous predictor of survival. J Trauma 27:1019-1024, 1987
13. Green FW, Jr, Kaplan MM, Curtis LE, et al: Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 74:38-43, 1978
14. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 341:586-592, 1999
15. Amitrano L, Guardascione MA, Brancaccio V, et al: Coagulation in liver disease. Semin Liver Dis 22:83-96, 2002
16. Noris M, Remuzzi G: Uremic bleeding: Closing the circle after 30 years of controversies? Blood 94:2569-2574, 1999
17. Siggaard-Anderson O, Salling N: Oxygen-linked hydrogen ion binding of human hemoglobin: Effects of carbon dioxide and 2,3-diphosphoglycerate. Scand J Clin Lab Invest 27: 361-366, 1971
18. Dzik WH, Kirkley SA: Citrate toxicity during massive blood transfusion. Transfus Med Rev 2:76-94, 1988
19. Deveras REA, Kessler CM: Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 137:884-888, 2002
20. Scharrer I: The need for highly purified products to treat hemophilia B. Acta Haematol 94suppl 1:2-7, 1005
21. Berguer R, Staerkel R, Moore E, et al: Warning: Fatal reaction to the use of fibrin glue in deep hepatic wounds: case reports. J Trauma 31:408-411, 1991
22. Streiff MB, Ness PM: Acquired FV inhibitors: A needless iatrogenic complication of bovine thrombin exposure. Transfusion 42:18-26, 2002
23. Pusateri AE, Holcomb JB, Bhattacharyya SN, et al: Different hypotensive responses to intravenous bovine and human thrombin preparations in swine. J Trauma 50:83-90, 2001
24. Hedner U, Erhardtsen E: Potential role of rFVIIa in transfusion medicine. Transfusion 42:114-124, 2002
25. Poon MC: Use of recombinant factor VIIa in hereditary bleeding disorders. Curr Opin Hemtol 8:312-318, 2001
26. Kristensen J, Killander A, Hippe E, et al: Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 26suppl 1:159-164, 1996
27. Hendricks HG, Meijer K, de Wolf JT, et al: Reduced transfusion requirement by recombinant factor VIIa in orthotopic liver transplantation: A pilot study. Transplantation 71: 402-405, 2001
28. Kenet G, Walden R, Eldad A, et al: Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879, 1999
29. O'Neill PA, Bluth M, Gloster ES, et al: Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. J Trauma 52:400-405, 2002
30. Martinowitz U, Kenet G, Segal E, et al: Recombinated activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51:431-438, 2001
31. Dutton RP, Hess JR, Scalea TM: Recombinant factor VIIa for control of hemorrhage: Early experience in critically ill trauma patients. J Clin Anesth 2003 (in press)
32. Martinowitz U, Holcomb JB, Pusateri AE, et al: Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 50:721-729, 2001
33. Schreiber MA, Holcomb JB, Hedner U, et al: The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries. J Trauma 53:252-257, 2002
34. Jeroukhimov I, Jewelewicz D, Zaias J, et al: Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury. J Tauma 53:1053-1057, 2002
35. Mannucci PM: Hemostatic drugs. N Engl J Med 339: 245-253, 1998
36. Sumann G, Kampfl A, Wenzel V, et al: Early intensive care unit intervention for trauma care: What alters the outcome. Curr Opin Crit Care 8:587-592, 2002
37. Chandler WL: Thromboelastography and the thromboelastograph technique. Semin Thromb Hemost 21suppl 4:1-6, 1995
38. Dzik S: The use of blood components prior to invasive bedside procedures: A critical appraisal, in Mintz PD (ed): Transfusion Therapy: Clinical Principles and Practice. Bethesda, MD, AAPP Press, 1999, pp 151-169
39. American Society of Anesthesiologists Task Force on Blood Component Therapy: Practice guidelines for blood component therapy. Anesthesiology 84:732-747, 1996
40. Stainsby D, MacLennan S, Hamilton PJ: Management of massive blood loss: A template guideline. Br J Anaesth 85:483-491, 2000
41. Ciavarella D, Reed RL, Counts RB, et al: Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 67:365-368, 1987
42. Reed RL, Ciavarella D, Heimbach DM, et al: Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical trial. Ann Surg 203:40-48, 1986
43. Bickell WH, Wall MJ Jr, Pepe PE, et al: Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 331:1105-1109, 1994
44. Dutton RP, Mackenzie CF, Scalea TM: Hypotensive resuscitation during active hemorrhage: Impact on in-hospital mortality. J Trauma 52:1141-1146, 2002
45. Hirshberg A, Walden R: Damage control for abdominal trauma. Surg Clin North Am 77:813-820, 1997
46. Holcomb JB, Pusateri AE, Harris RA, et al: Dry fibrin sealant dressings reduce blood loss and improve survival in hypothermic coagulopathic swine with grade V liver injury. J Trauma 46:233-242, 1999
47. O'Sullivan J, O'Sullivan: Trauma-induced coagulopathy and treatment in Kosovo. Mil Med 166:362-365, 2001
48. Hiippala S: Replacement of massive blood loss. Vox Sang 74suppl 2:399-407, 1998
49. Wudel JH, Morris JA Jr, Yates K, et al: Massive transfusion: Outcome in blunt trauma patients. J Trauma 31:1-7, 1991